↓ Skip to main content

Designer drugs 2015: assessment and management

Overview of attention for article published in Addiction Science & Clinical Practice, March 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)

Mentioned by

policy
1 policy source
twitter
14 tweeters
facebook
4 Facebook pages
reddit
1 Redditor

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
172 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Designer drugs 2015: assessment and management
Published in
Addiction Science & Clinical Practice, March 2015
DOI 10.1186/s13722-015-0024-7
Pubmed ID
Authors

Michael F Weaver, John A Hopper, Erik W Gunderson

Abstract

Recent designer drugs, also known as "legal highs," include substituted cathinones (e.g., mephedrone, methylone, and methylenedioxypyrovalerone, often referred to as "bath salts"); synthetic cannabinoids (SCs; e.g., Spice); and synthetic hallucinogens (25I-NBOMe, or N-bomb). Compound availability has evolved rapidly to evade legal regulation and detection by routine drug testing. Young adults are the primary users, but trends are changing rapidly; use has become popular among members of the military. Acute toxicity is common and often manifests with a constellation of psychiatric and medical effects, which may be severe (e.g., anxiety, agitation, psychosis, and tachycardia), and multiple deaths have been reported with each of these types of designer drugs. Clinicians should keep designer drugs in mind when evaluating substance use in young adults or in anyone presenting with acute neuropsychiatric complaints. Treatment of acute intoxication involves supportive care targeting manifesting signs and symptoms. Long-term treatment of designer drug use disorder can be challenging and is complicated by a lack of evidence to guide treatment.

Twitter Demographics

The data shown below were collected from the profiles of 14 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 172 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Canada 1 <1%
Unknown 170 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 41 24%
Student > Master 30 17%
Student > Postgraduate 16 9%
Other 15 9%
Researcher 14 8%
Other 39 23%
Unknown 17 10%
Readers by discipline Count As %
Medicine and Dentistry 59 34%
Chemistry 24 14%
Psychology 17 10%
Pharmacology, Toxicology and Pharmaceutical Science 15 9%
Agricultural and Biological Sciences 10 6%
Other 26 15%
Unknown 21 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2021.
All research outputs
#1,726,533
of 16,983,585 outputs
Outputs from Addiction Science & Clinical Practice
#58
of 305 outputs
Outputs of similar age
#28,643
of 229,300 outputs
Outputs of similar age from Addiction Science & Clinical Practice
#1
of 1 outputs
Altmetric has tracked 16,983,585 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 305 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 229,300 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them